PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
PolyPid will host a virtual Investor Day on October 28, 2026, at 11:30 a.m. ET, where management will outline its 'PolyPid 2030' long-term growth and pipeline strategy. The event will include an update on lead candidate D-PLEX100, whose NDA is under FDA Priority Review with a PDUFA goal date of November 28, 2026, and will introduce PD01B, a new candidate for diabetic foot infections based on the Kynatrix delivery technology. KOL Dr.
Key figures
- Event date
- October 28, 2026
- Pdufa goal date
- November 28, 2026
- Shield ii relative risk reduction
- 60%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.